REVIEW ARTICLE inTroducTion
Hepatitis B virus (HBV) is a member of the family Hepadnaviridae, whereas hepatitis C virus (HCV) is a member of the family Flaviviridae. Both HBV and HCV are hepatotropic viruses that cause liver inflammation (1-3). These viruses can establish chronic persistent infections that are accompanied by immune-mediated liver injury in the infected host. The infection evolves to chronic persistent infection in more than 70% of HCVinfected adults and approximately 90% of HBV-infected neonates due to vertical transmission (4). Infected patients have a high risk of developing liver cirrhosis and hepatocellular carcinoma once a chronic persistent infection is established by either HBV or HCV (5).
It has been demonstrated that virus-specific T cell responses are critical for the control of virus during HBV or HCV infection (6). In particular, adequate T cell responses are essential for spontaneous resolution of acute HBV or HCV infection and to prevent chronic persistent infection (3,7). Indeed, depletion of either CD4 + or CD8 +
T cells disturbs viral clearance in challenge experiments
with HBV or HCV in chimpanzees (8-10). However, T cells also contribute to liver injury during HBV and HCV infection. In particular, the finding that intrahepatic infiltration of T cells coincides with the increase of serum alanine aminotransferase (ALT) levels during acute HBV or HCV infection supports the important role of T cells in liver injury (4,7,11). However, the exact mechanism of T cell-mediated liver injury has not been elucidated. 
Foxp3
low cytokine-secreting non-suppressive cells was increased in patients with acute-on-chronic liver failure and correlated with severe liver injury (34). These data indicate that analyses of the Treg cell subpopulation better delineate disease status than analyses of the total Treg cell population. 
Treg cells in viral infecTion
Treg cells play a crucial role in suppressing immune responses to self-antigens and in controlling autoimmune diseases. However, Treg cells also modulate immune responses to infectious pathogens, including bacteria, viruses, parasites, and fungi (35).
It has been shown that Treg cells regulate effector T cell responses against viruses such as herpes simplex virus (HSV), human immunodeficiency virus (HIV), and simian immunodeficiency virus (SIV) (17,36,37). Effective virus-specific T cell responses are critical for eliminating the virus. However, several viruses can escape the T cell response and promote viral persistence. Treg cells play a role in the suppression of antiviral T cell responses during this process and aid the establishment of viral persistence. In viral infection, Treg cells also contribute to host protection by preventing excessive immunopathological host damage caused by sustained immune activation and inflammation (38,39). For example, the role of Treg cells was clearly described in a murine model of corneal HSV infection (16). In this study, depletion of Treg cells prior to HSV challenge resulted in more severe eye inflammation by enhanced effector T cell infiltration. Furthermore, adoptive transfer of Treg cells reduced the severity of eye inflammation, indicating that Treg cells play a beneficial role by suppressing immunopathology and inflammation during viral infection. 
Treg cells in hbv infecTion

Treg cells in hcv infecTion
There are limited data describing Treg cells in acute HCV infection, which commonly leads to persistent infection. One study compared circulating Treg cells in patients with acute HCV infection who progressed to chronic infection with those in patients who spontaneously resolved the infection (49) . The results demonstrated that chronic progression was associated with long-term maintenance of Treg cells, whereas spontaneous recovery in the acute stage was associated with temporal loss of the suppressive function of Treg cells. This result suggests that Treg cells are key determinants of spontaneous resolution vs chronic progression of acute HCV infection.
Several studies of patients with chronic HCV infection revealed an increased frequency of CD4 + CD25
+ Treg cells in the peripheral blood compared with spontaneously resolving patients or healthy controls (50) (51) (52) . Increased Treg cell frequencies in the liver have also been observed in chronically infected patients (53, 54) . However, it is uncertain whether these Treg cells are nTreg or iTreg cells induced by HCV antigens. Interestingly, Treg cells from chronically infected patients exhibit significantly higher suppressive activity against T cell proliferation and IFN-γ secretion (55). However, Treg cells from HCV-infected individuals inhibit CD8 + T cells in an antigen-nonspecific manner and suppress not only HCV-specific T cells but also influenza-, CMV-, and EBV-specific T cells (53, 55 
Foxp3
+ cells in intrahepatic immune regulation (54) 
One study showed that CD4 + CD25 + Foxp3 + Treg cells suppress not only IFN-γ production and the proliferation of HCV-specific T cells but also activation-induced cell death of HCV-specific T cells in HCV-exposed chimpanzees, including both hosts spontaneously recovered from HCV infection and hosts with chronic HCV infection (58). Therefore, it was suggested that Treg cells might control HCV-specific memory T cell responses by limiting their activation and preventing apoptosis in hosts who have recovered from HCV infection. A detailed analysis of the CD4 + CD25 + Foxp3 + population in chimpanzees revealed that Treg cells from chronically infected and recovered chimpanzees displayed fewer T cell receptor excision circles than Treg cells from HCVnaïve chimpanzees, indicating that the cells underwent more proliferation as a result of HCV infection.
In addition to CD4 + CD25 + Foxp3 + Treg cells, CD8 + T cells with regulatory functions have been studied in patients with HCV infection. HCV-specific CD8 + T cells that produce IL-10 were identified in the livers of chronically infected patients by in situ immunostaining (59). Previous studies have demonstrated that IL-10-producing CD8 + T cells protect against liver cirrhosis by reducing hepatocellular apoptosis, indicating their role in decreasing liver damage (59). Accapezzato et al. showed that the anti-viral function of HCV-specific effector CD8 + T cells infiltrating the liver was not efficient in patients with chronic HCV infection because of the concomitant presence of virus-specific CD8 + T cells producing considerable amounts of IL-10 (60). This finding suggests that IL-10-producing CD8 + T cells contribute to viral persistence by controlling hepatic effector CD8 + T cell responses. TGF-b-secreting, HCV-specific CD8 + T cells were also identified in the blood of patients with chronic HCV infection (61). When TGF-b secretion was blocked, the peripheral HCV-specific T cell responses were enhanced despite the presence of HIV co-infection.
conclusions
The function of Treg cells may be a double-edged sword in hepatitis viral infections. Although Treg cells suppress T cell responses directed against the hepatitis viruses, they also play a protective role by downregulating immunemediated mechanisms of liver damage. However, it is unclear whether these different roles are attributed to identical Treg populations or distinct Treg subpopulations. In addition, it remains to be elucidated whether these two different roles are mediated by identical suppression mechanisms or by distinct mechanisms. A more detailed understanding of Treg cells in hepatitis viral infections will broaden our knowledge of immune responses and immunopathology in viral hepatitis and may provide new therapeutic targets for clinical applications. 
